Endocrine Disruptors

16 - 17 September 2024 - Berlin und online


Key Topics

  • Impact of the EU’s Green Deal
  • ED Regulation: Regional Specifics
  • Study Requirements
  • Impact on CLP
  • NAMs – Experiences so far


Presenting Institutions and Companies

  • Jordane Wodli, European Commission
  • Maristella Rubbiani, European Commission
  • Scott Lynn, PhD, US EPA
  • Kunihiko Yamazaki, Ministry of the Environment, Government of Japan
  • Dr Christian Unkelbach, Federal Office for Chemicals (BfC), Federal Institute for Occupational Safety and Health (BAuA), Germany
  • Dr Philip Marx-Stölting, BfR German Federal Institute for Risk Assessment
  • Prof Dr Lennart Weltje, BASF SE, Germany
  • Dr Volker J. Soballa, Evonik Industries AG, Germany
  • Dr Natalie Burden, NC3Rs, United Kingdom
  • Dr Melanie Lichtenberger, ibacon GmbH, Germany
  • Dr Christian Kirchnawy, OFI Technologie & Innovation GmbH, Austria
  • Dr James Wheeler, Corteva Agriscience, The Netherlands
  • Andy Adams, PhD, FleishmanHillard, France
  • Dr Heli Hollnagel, Dow Europe / The Dow Chemical Company, Switzerland
  • Jelena Buha, PhD, Zurich Insurance Group Ltd, Switzerland
  • Darren Abrahams, Partner, Avocat, Barrister, Steptoe LLP, Belgium